Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 273 | 3 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//DRUG METABOLISM AND DISPOSITION | 43782 |
| 812 | 2 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//MDR1 | 12153 |
| 38525 | 1 | IN VITRO CARCINOGENESIS CELLULAR CHEMOTHER//VITRO CARCINOGENESIS CELLULAR CHEMOTHER Y//2 HYDROXY HIPPURIC ACID 2HHA | 60 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | IN VITRO CARCINOGENESIS CELLULAR CHEMOTHER | address | 3501899 | 17% | 67% | 10 |
| 2 | VITRO CARCINOGENESIS CELLULAR CHEMOTHER Y | address | 3089909 | 17% | 59% | 10 |
| 3 | 2 HYDROXY HIPPURIC ACID 2HHA | authKW | 525286 | 2% | 100% | 1 |
| 4 | ANAPHALIS LACTEAL | authKW | 525286 | 2% | 100% | 1 |
| 5 | ANTHRAQUINONE ANTITUMOUR DRUGS | authKW | 525286 | 2% | 100% | 1 |
| 6 | BENZOPERIMIDINE BP1 | authKW | 525286 | 2% | 100% | 1 |
| 7 | CANCER BIOMARKER TESTS | authKW | 525286 | 2% | 100% | 1 |
| 8 | COPPER II 2 HYDROXY HIPPURATE DEHYDRATE CUHAH2O2CUHA | authKW | 525286 | 2% | 100% | 1 |
| 9 | COPPER II N 2 HYDROXY 3 METHOXY BENZALDEHYDE ALANINATE | authKW | 525286 | 2% | 100% | 1 |
| 10 | COPPER II N 2 HYDROXYACETOPHENONE GLYCINATE | authKW | 525286 | 2% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 108 | 23% | 0% | 14 |
| 2 | Pharmacology & Pharmacy | 70 | 22% | 0% | 13 |
| 3 | Cell Biology | 65 | 18% | 0% | 11 |
| 4 | Biochemistry & Molecular Biology | 57 | 28% | 0% | 17 |
| 5 | Chemistry, Medicinal | 24 | 7% | 0% | 4 |
| 6 | Medicine, Research & Experimental | 22 | 8% | 0% | 5 |
| 7 | Primary Health Care | 15 | 2% | 0% | 1 |
| 8 | Chemistry, Inorganic & Nuclear | 8 | 5% | 0% | 3 |
| 9 | Biophysics | 7 | 5% | 0% | 3 |
| 10 | Chemistry, Applied | 4 | 3% | 0% | 2 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | IN VITRO CARCINOGENESIS CELLULAR CHEMOTHER | 3501899 | 17% | 67% | 10 |
| 2 | VITRO CARCINOGENESIS CELLULAR CHEMOTHER Y | 3089909 | 17% | 59% | 10 |
| 3 | IMIB UMUMURCIA BIOHEALTH MED | 525286 | 2% | 100% | 1 |
| 4 | INVITRO CARCINOGENESIS CELLULAR CHEMOTHERA | 525286 | 2% | 100% | 1 |
| 5 | KEY STATE S | 525286 | 2% | 100% | 1 |
| 6 | ENVIRONM CARCINOGENESIS TOXICOL | 386231 | 8% | 15% | 5 |
| 7 | DIPARTIMENTO EMATOL SCI ONCOL LEA SERAGNOLI | 262642 | 2% | 50% | 1 |
| 8 | DIPARTIMENTO SCI MOTORIE SALUTE | 262638 | 5% | 17% | 3 |
| 9 | HOSP UNIT | 205541 | 5% | 13% | 3 |
| 10 | INTER GRP HLTH ECON GRIDES | 175094 | 2% | 33% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BIOMETALS | 2666 | 5% | 0% | 3 |
| 2 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1242 | 5% | 0% | 3 |
| 3 | DRUG RESISTANCE UPDATES | 1070 | 2% | 0% | 1 |
| 4 | CELL DEATH AND DIFFERENTIATION | 633 | 3% | 0% | 2 |
| 5 | ANTI-CANCER DRUGS | 626 | 3% | 0% | 2 |
| 6 | THERAPEUTICS AND CLINICAL RISK MANAGEMENT | 602 | 2% | 0% | 1 |
| 7 | INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 489 | 2% | 0% | 1 |
| 8 | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | 444 | 2% | 0% | 1 |
| 9 | BIOMEDICINE & PHARMACOTHERAPY | 413 | 3% | 0% | 2 |
| 10 | RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY | 347 | 2% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |